Beijing Succeeder Technology Inc. (688338.SS)

CNY 25.18

(-0.98%)

Market Cap (In CNY)

2.67 Billion

Revenue (In CNY)

275.48 Million

Net Income (In CNY)

116.91 Million

Avg. Volume

479.32 Thousand

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
18.49-34.23
PE
-
EPS
-
Beta Value
0.493
ISIN
CNE1000044C4
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Ms. Zhonghui Ding
Employee Count
-
Website
https://www.succeeder.com.cn
Ipo Date
2020-08-06
Details
Beijing Succeeder Technology Inc. engages in the research and development, manufacture, and sale of in-vitro diagnostic products in China and internationally. Its products include coagulation analyzers and reagents, blood rheology analyzers, ESR analyzers, and platelet aggregation analyzers. The company was founded in 2003 and is headquartered in Beijing, China.